245 related articles for article (PubMed ID: 20861806)
1. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand.
Scott DR; Wong JK; Spicer TS; Dent H; Mensah FK; McDonald S; Levy MT
Transplantation; 2010 Dec; 90(11):1165-71. PubMed ID: 20861806
[TBL] [Abstract][Full Text] [Related]
2. Reduction in cardiovascular death after kidney transplantation.
Pilmore H; Dent H; Chang S; McDonald SP; Chadban SJ
Transplantation; 2010 Apr; 89(7):851-7. PubMed ID: 20048695
[TBL] [Abstract][Full Text] [Related]
3. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients.
Gentil Govantes MA; Esforzado N; Cruzado JM; González-Roncero FM; Balaña M; Saval N; Morales JM
Transplantation; 2012 Dec; 94(11):1131-7. PubMed ID: 23104249
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
[TBL] [Abstract][Full Text] [Related]
5. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
6. Renal transplantation offers a better survival in HCV-infected ESRD patients.
Sezer S; Ozdemir FN; Akcay A; Arat Z; Boyacioglu S; Haberal M
Clin Transplant; 2004 Oct; 18(5):619-23. PubMed ID: 15344970
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients.
Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L
Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548
[TBL] [Abstract][Full Text] [Related]
8. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C, acute humoral rejection, and renal allograft survival.
Forman JP; Tolkoff-Rubin N; Pascual M; Lin J
J Am Soc Nephrol; 2004 Dec; 15(12):3249-55. PubMed ID: 15579529
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients.
Glicklich D; Thung SN; Kapoian T; Tellis V; Reinus JF
Am J Gastroenterol; 1999 Jan; 94(1):159-63. PubMed ID: 9934748
[TBL] [Abstract][Full Text] [Related]
11. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis C virus infection in renal-transplant patients].
Kamar N; Izopet J; Ribes D; Rostaing L
Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of children with end-stage renal disease.
McDonald SP; Craig JC;
N Engl J Med; 2004 Jun; 350(26):2654-62. PubMed ID: 15215481
[TBL] [Abstract][Full Text] [Related]
15. Natural history of hepatitis C virus infection in adult renal graft recipients.
Aroldi A; Lampertico P; Montagnino G; Lunghi G; Passerini P; Villa M; Campise M; Cesana BM; Ponticelli C
Transplant Proc; 2005 Mar; 37(2):940-1. PubMed ID: 15848581
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
17. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C infection and the patient with end-stage renal disease.
Fabrizi F; Poordad FF; Martin P
Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
[TBL] [Abstract][Full Text] [Related]
19. Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.
Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW;
Nephrol Dial Transplant; 2006 Mar; 21(3):776-83. PubMed ID: 16280374
[TBL] [Abstract][Full Text] [Related]
20. Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.
Bose B; McDonald SP; Hawley CM; Brown FG; Badve SV; Wiggins KJ; Bannister KM; Boudville N; Clayton P; Johnson DW
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2657-61. PubMed ID: 21903989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
